Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...
RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.
writing is a tool we already use everyday. Unlike other forms of expression — say sculpting masterpieces or playing concertos — it’s a muscle we flex on demand for classes in the form of ...
Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...
The best free writing app and software helps you get your ideas down on the page, with tools to help manage, organize, and plot your latest work. My team and I have tested a range of the best free ...
Vertex Pharmaceuticals has analysts doing financial backflips as they boost its price targets, with Royal Bank of Canada ...
Despite a market bloodbath that left the S&P 500 down 4.84%, Vertex Pharmaceuticals managed a modest gain of 0.11%, flaunting resilience. The biotech firm outpaced the broader medical sector over the ...
Efforts by retired and future educators helped provide for a list of recent donations to the Ronald McDonald House in Jackson.
Theatre at USD is home to actors, directors, playwrights and designers of the future. Our major, minor and MFA programs embrace theatre as a means to inspire humanity and engage a diverse society.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results